Smith Mark Douglas
CIK 0001756253
Director
Filings
17
Latest May 21, 2026
Issuers covered
3
Showing
17 of 17
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 43% | +1.7% | -2.1% | +15.6% | -9.7% |
| 90 days | 7 | 100% | +11.6% | +7.9% | +35.6% | +1.1% |
| 180 days | 7 | 86% | +30.8% | +40.2% | +84.7% | -15.3% |
| 365 days | 6 | 67% | +10.8% | +13.4% | +25.3% | -12.5% |
Issuers
Companies where Smith Mark Douglas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TDOC | Teladoc Health, Inc. | 7 | May 21, 2026 |
| PHR | Phreesia, Inc. | 6 | Jul 3, 2025 |
| JAZZ | Jazz Pharmaceuticals PLC | 4 | Aug 11, 2025 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|